The U.S. Department of Justice (DOJ) is urging a court to dismiss a report from a special master in a protracted fraud case against UnitedHealth related to Medicare Advantage. The government claims that UnitedHealth has failed to refund at least $2 billion in overpayments to Medicare Advantage, a situation that has been ongoing for several years. Meanwhile, the Federal Trade Commission (FTC) is resuming its lawsuit against pharmacy benefit managers (PBMs) regarding inflated insulin prices, which had been temporarily stalled due to a lack of commissioners. FTC Chair Lina Khan is expected to participate in the case against CVS Caremark, Express Scripts, and OptumRx, as the agency seeks to address pricing practices in the pharmaceutical industry. Additionally, a federal judge overseeing numerous opioid lawsuits is facing a recusal request over alleged improper communications, which adds another layer of complexity to ongoing legal challenges in the healthcare sector.